By Professor Michael Proinsias Farrell

Journal articles

Varghese C; Peters L; Gaborit L; Xu W; Kalyanasundaram K; Basam A; Park M; Wells C; McLean KA; Schamberg G; O’Grady G; Wright D; Martin J; Harrison E; Pockney P; Reinke C; Kaiser N; Werenski H; Nimeri A; Benham E; Yue T; Knowlton L; Fariyike B; Narayan A; Titan A; Painter M; Craig-Lucas A; Farrell M; Kus ZC; Akbuz SO; Mutlu M; Hokelekli F; Tuzuner F; Durmus E; Cetınkaya ZS; Yilmaz H; Yavuz D; Korkmaz DS; Kazbek BK; Koksoy UC; Şenödeyici E; Aydoğdu EO; Ajredini M; Omur M; Yavuz I; Cakcak IE; Akdere H; Kaya E; Bayram C; Durdu B; Dindar A; Certel AT; Ulkucu A; Sarı AC; Uyanık MS; Candan M; Kara ME; Çolak E; Polat S; Kayilioglu I; Kocyigit GZ; Tabak EZ; Fergar C; Akkaya EN; Baltacı ZH; Uğurlu MÜ; Saraçoğlu A; Aral C; Uprak TK; Kayabaş İ; Elieyioğlu G; Camkıran E; Taşcı ME; Şen E; Korkmaz E; Gemici A; Düzyol Z; Ozbilen M; Gecici ME; Kale A; Selim K; Ulusahin M; Kodalak TA; Kıralı N; Yuzgec AN; Reis ME; Cepe H; Yıldız B; Baysallar D; Guner A; Pehlivan D; Akın B; Gündoğdu A; Tepe MD; Kara Y; Bozkurt MA; Telci H; Sibic O; Ozdemir Z; Uludag SS, 2025, 'Predicting opioid consumption after surgical discharge: a multinational derivation and validation study using a foundation model', Npj Digital Medicine, 8, http://dx.doi.org/10.1038/s41746-025-01798-6

Tegge AN; Ferreira MAR; Garafola PM; Xu S; Farrell M; Marsden J; Lee K; Le Moigne A; Gray F; Bickel WK, 2025, 'Treatment and recovery from opioid use disorder: The role of pain severity in individuals with moderate to severe pain', Drug and Alcohol Dependence, 276, http://dx.doi.org/10.1016/j.drugalcdep.2025.112902

Darke S; Farrell M; Duflou J; Copeland C; Roberts E, 2025, 'Drugs and Drowning: The Toxicology of Adult Drownings in Baths and Hot Tubs in Australia, 2015–2024', Drug and Alcohol Review, 44, pp. 1811 - 1815, http://dx.doi.org/10.1111/dar.70005

Economidis G; Lynch M; Taylor S; Asare-Doku W; Macpherson G; Degenhardt L; Farrell M; Santo T, 2025, 'Global Perspectives on Kava: A Narrative Systematic Review of the Health Effects, Economic and Social Impacts and Policy Considerations', Drug and Alcohol Review, 44, pp. 1601 - 1640, http://dx.doi.org/10.1111/dar.14080

Santo TJ; Chaillon A; Martin N; Hickman M; Jones N; Farrell M; Bharat C; Degenhardt L; Borquez A, 2025, 'Quantifying the impact of a large-scale opioid agonist treatment program on suicide prevention in New South Wales, Australia: A data-modeling study', Addiction, 120, pp. 1601 - 1609, http://dx.doi.org/10.1111/add.70018

Darke S; Duflou J; Peacock A; Lim J; Havard A; Farrell M; Lappin J, 2025, 'Characteristics of deaths related to lithium toxicity in Australia, 2000–2024', Australian and New Zealand Journal of Psychiatry, 59, pp. 622 - 628, http://dx.doi.org/10.1177/00048674251336037

Darke S; Farrell M; Hall W; Lappin J, 2025, '‘Deaths of despair’: A term that needs to be retired', Addiction, 120, pp. 1072 - 1074, http://dx.doi.org/10.1111/add.70030

Woods A; Foley C; Conigrave KM; Asare-Doku W; Shakeshaft A; Settumba-Stolk S; Farrell M; Doyle M; Stolk SS, 2025, 'Extended-release pharmacotherapies for substance use disorders in incarcerated populations: A systematic review', Addiction, 120, pp. 835 - 859, http://dx.doi.org/10.1111/add.16766

Jones N; Ghouse FN; Gibson A; Tran DT; Santo T; Bharat C; Farrell M; Degenhardt L, 2025, 'Data Resource Profile Update: The Opioid Agonist Treatment and Safety II (OATS II) Study, 2001–22, New South Wales, Australia', International Journal of Epidemiology, 54, http://dx.doi.org/10.1093/ije/dyaf037

Weatherburn D; Rahman S; Todd S; Poynton S; Black S; Merinda T; Farrell M, 2025, 'The impact of a voluntary alcohol and other drug diversion program on reoffending, imprisonment, and health', International Journal of Drug Policy, 138, pp. 104747, http://dx.doi.org/10.1016/j.drugpo.2025.104747

Darke S; Peacock A; Duflou JA; Farrell M; Lappin J, 2025, 'Methylphenidate and (lis)dexamfetamine toxicity-related deaths of adults, Australia, 2000–24: analysis of NCIS data', Medical Journal of Australia, 222, pp. 259 - 261, http://dx.doi.org/10.5694/mja2.52604

Pocuca N; Campbell G; Barnett A; Beck AK; Ellem R; Quinn CA; Kelly PJ; Larance B; Baker AL; Connor JP; Marsden J; Chan GCK; Connelly L; Lenzen S; Farrell M; Stirling R; Hudson S; Hides L, 2025, 'A mixed-methods study of staff perspectives on the barriers and facilitators to the implementation of patient-reported routine outcome measures and feedback in alcohol and other drug treatment', Drug and Alcohol Review, 44, pp. 759 - 771, http://dx.doi.org/10.1111/dar.14007

Bharat C; Hopkins RE; Chambers M; Degenhardt L; Peacock A; Farrell M; Yuen WS; Man N; Gisev N, 2025, 'Age, period, and cohort trends of substance poisoning, alcohol-related disease, and suicide deaths in Australia, 1980–2019', Social Psychiatry and Psychiatric Epidemiology, 60, pp. 693 - 703, http://dx.doi.org/10.1007/s00127-024-02749-4

Santo T; Chaillon A; Martin N; Bharat C; Jones N; Farrell M; Hickman M; Borquez A; Degenhardt L, 2025, 'Quantifying the Impact of Opioid Agonist Treatment on Suicide Mortality in New South Wales, Australia: A Population-Level Analysis from 2001 to 2020', DRUG AND ALCOHOL DEPENDENCE, 267, http://dx.doi.org/10.1016/j.drugalcdep.2024.112133

Darke S; Farrell M; Lappin J, 2025, 'Rare but relevant series', Addiction, 120, pp. 197, http://dx.doi.org/10.1111/add.16697

Asare-Doku W; Peacock A; Settumba S; Abbott T; Wilson K; Craig A; Ravulo J; Economidis G; Meo-Sewabu L; D'Este C; Thapa P; Doran C; Nathan S; Waller E; Satour T; Tulele L; Farrell M; Shakeshaft A, 2025, 'Assessing the Early Impact of the Change in the Kava Importation Policy in Australia', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.70039

Darke S; Duflou J; Chrzanowska A; Farrell M; Lappin J; Peacock A, 2025, 'Changes in the rates and characteristics of gamma hydroxybutyrate (GHB)-related death in Australia, 2001–2023', Drug and Alcohol Review, 44, pp. 366 - 375, http://dx.doi.org/10.1111/dar.13940

Darke S; Duflou J; Lappin J; Farrell M; Peacock A, 2025, 'Characteristics and toxicology of adult deaths due to quetiapine toxicity in Australia, 2000–2024', Journal of Forensic Sciences, http://dx.doi.org/10.1111/1556-4029.70124

Roberts E; Copeland C; Darke S; Farrell M, 2025, 'Characteristics of drug-related deaths where individuals are found submerged in a bath or hot tub in the United Kingdom, 1997–2023', Drug and Alcohol Review, 44, pp. 347 - 354, http://dx.doi.org/10.1111/dar.13950

Darke S; Duflou J; Farrell M; Lappin J; Peacock A, 2025, 'Clinical characteristics of heroin overdose deaths among older adults in Australia, 2000–2025', Addiction, http://dx.doi.org/10.1111/add.70216

Bryant J; Shakeshaft A; Lintzeris N; Haber P; Farrell M; Dizon J; Freund M, 2025, 'Factors Associated With Alcohol Use Among Individuals Commencing Treatment at Community-Based Outpatient Treatment Centres in Australia', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.70034

Settumba S; Shahbazi J; Byrne M; Degenhardt L; Grebely J; Larance B; Nielsen S; Lintzeris N; Ali R; Rodgers C; Blazey A; Weiss R; Dunlop A; McDonough M; Cook J; Farrell M, 2025, 'Provider costs of treating opioid dependence with extended-release buprenorphine in Australia', Drug and Alcohol Review, 44, pp. 179 - 194, http://dx.doi.org/10.1111/dar.13956

Darke S; Farrell M; Duflou J; Lappin J; Chrzanowska A; Peacock A, 2025, 'Rates and Clinical Characteristics of Self-Administered Fatal Ketamine-Related Poisoning in Australia, 2000–2025', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.70058

Pocuca N; Tisdale C; Campbell G; Beck AK; Ellem R; Quinn CA; Kelly PJ; Larance B; Baker AL; Connor JP; Marsden J; Chan GCK; Connelly L; Lenzen S; Farrell M; Hides L, 2025, 'Routine outcome monitoring and feedback in alcohol and other drug treatment: A qualitative study of client perspectives on implementation', Drug and Alcohol Review, 44, pp. 226 - 238, http://dx.doi.org/10.1111/dar.13962

Ezard N; Clifford B; Siefried KJ; Ali R; Dunlop A; McKetin R; Bruno R; Carr A; Ward J; Farrell M; Graham R; Haber P; Lubman D; Donoghoe MW; Olsen N; Baker A; Hall M; Arunogiri S; Lintzeris N; Gill A; Rodgers C; Montebello M; Liaw W; Liu Z, 2025, 'Lisdexamfetamine in the treatment of methamphetamine dependence: A randomised, placebo-controlled trial', Addiction, 120, pp. 1345 - 1359, http://dx.doi.org/10.1111/add.16730

Courtney RJ; Howard BC; Barker D; Petrie D; Borland R; Shakeshaft A; Gartner C; Mendelsohn C; Boland VC; Henderson A; Richmond RL; Tutka P; Naughton F; Hall W; Zwar N; Farrell M; Mattick RP; McRobbie H, 2025, 'Vaporized Nicotine Products for Smoking Cessation Among People Experiencing Social Disadvantage A Randomized Clinical Trial', ANNALS OF INTERNAL MEDICINE, 178, http://dx.doi.org/10.7326/ANNALS-24-03531

McKetin R; Degan TJ; Saunders L; Nguyen L; Dore G; Shoptaw S; Farrell M; Degenhardt L; Kelly PJ; Turner A; Clare PJ; Dean OM; Arunogiri S; Colledge-Frisby S; Koeijers J; Goodman-Meza D; Sinclair B; Reid D; Hill H; Hayllar J; Christmass M; Cordaro F; Lundin R; Liaw W; Liu D; Holyoak E; Wu BTF; Keygan J; Kontogiannis A; Palmer L; Morrison C; Wrobel A; Hyland B; Byrne M; Russell S; Zahra E; Berk M, 2024, 'A phase 3 randomised double-blind placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine use disorder: a study protocol for the Tina Trial', Trials, 25, http://dx.doi.org/10.1186/s13063-024-08238-y

Zahra E; Darke S; Lappin J; Duflou J; Farrell M, 2024, 'Baclofen-related deaths in Australia 2000–2022', Forensic Science International, 365, http://dx.doi.org/10.1016/j.forsciint.2024.112281

Weatherburn D; Farrell M; Wan WY; Rahman S, 2024, 'The criminal careers of Australian drug traffickers', International Journal of Drug Policy, 134, pp. 104650, http://dx.doi.org/10.1016/j.drugpo.2024.104650

Darke S; Duflou J; Farrell M; Lappin J; Peacock A, 2024, 'Emergence of deaths due to nitazene toxicity in Australia', Drug and Alcohol Review, 43, pp. 2093 - 2094, http://dx.doi.org/10.1111/dar.13920

Farnbach S; Foley C; Gates P; Seccull A; Henderson A; Zocco A; Farrell M; Shakeshaft A, 2024, 'Enhancing the SUSTAINable uptake of evidence to minimise harms from alcohol and other drugs in New South Wales, Australia', Drug and Alcohol Review, 43, pp. 1781 - 1786, http://dx.doi.org/10.1111/dar.13843

Heijstee N; Black E; Black E; Demirkol A; Mammen K; Mills L; Deacon R; Ezard N; Montebello M; Reid D; Bruno R; Shakeshaft A; Siefried KJ; Farrell M; Lintzeris N, 2024, 'Sociodemographic and Health Factors of the Alcohol Treatment-seeking Population in New South Wales, Australia', Journal of Addiction Medicine, 18, pp. 619 - 627, http://dx.doi.org/10.1097/ADM.0000000000001311

Wardle H; Degenhardt L; Marionneau V; Reith G; Livingstone C; Sparrow M; Tran LT; Biggar B; Bunn C; Farrell M; Kesaite V; Poznyak V; Quan J; Rehm J; Rintoul A; Sharma M; Shiffman J; Siste K; Ukhova D; Volberg R; Salifu Yendork J; Saxena S, 2024, 'The Lancet Public Health Commission on gambling', Lancet Public Health, 9, pp. e950 - e994, http://dx.doi.org/10.1016/S2468-2667(24)00167-1

Darke S; Duflou J; McDonald S; Peacock A; Farrell M; Lappin J, 2024, 'Neuropathology of deaths due to acute alcohol toxicity in Australia, 2011–2022', Drug and Alcohol Dependence, 263, http://dx.doi.org/10.1016/j.drugalcdep.2024.111407

Darke S; Duflou J; Peacock A; Farrell M; Hall W; Lappin J, 2024, 'A retrospective study of the characteristics and toxicology of cases of lysergic acid diethylamide (LSD)- and psilocybin-related death in Australia', Addiction, 119, pp. 1564 - 1571, http://dx.doi.org/10.1111/add.16518

Macdonald C; Macpherson G; Leppan O; Tran LT; Cunningham EB; Hajarizadeh B; Grebely J; Farrell M; Altice FL; Degenhardt L, 2024, 'Interventions to reduce harms related to drug use among people who experience incarceration: systematic review and meta-analysis', Lancet Public Health, 9, pp. e684 - e699, http://dx.doi.org/10.1016/S2468-2667(24)00160-9

Gaborit L; Kalyanasundaram K; Vu J; Basam A; Elhadi M; Wright D; Martin J; Park M; Pockney P; Ntalouka M; Abubaker N; Saeed U; Abdulwahed E; Alsori M; Alrifae GMH; Farrell M; Liu G; Smith N; Xu W; Varghese C; Harrison E; Goh S; Li J; Shah J; Waraich A; Pathak U; Hilder A; Jabur A; Ohis C; Ong CF; Siribaddana V; Raubenheimer K; Wells C; Ferguson L; Xu W; Pockney P; Atherton K; Dawson A; Martin J; Banerjee A; Dudi-Venkata N; Lightfoot N; Ludbrook I; Peters L; Sara R; Watson D; Adeyeye A; Alvarez-Lozada LA; Atici SD; Buhavac M; Calini G; Ioannidis O; Tepe MD; Nath U; Uzair A; Yang W; Zaidi F; Singh S; Abdullah B; Palacios DSG; Ragab A; Ahmed A; Daudu D; Goh S; Benyani SV; Karthikeyan N; Mansour LT; Seow W; Tasi Z; Abdelmelek DE; Boussahel IFZ; Kaabache O; Lemdaoui N; Nebbar O; Rais M; Abdoun M; Kouicem AT; Bouaoud S; Bouchenak K; Saada H; Ouyahia A; Messai W; Choong ZS; Ting C; Larkin M, 2024, 'Patterns of opioid use after surgical discharge: a multicentre, prospective cohort study in 25 countries', Anaesthesia, 79, pp. 924 - 936, http://dx.doi.org/10.1111/anae.16297

Tran LT; Wardle H; Colledge-Frisby S; Taylor S; Lynch M; Rehm J; Volberg R; Marionneau V; Saxena S; Bunn C; Farrell M; Degenhardt L, 2024, 'The prevalence of gambling and problematic gambling: a systematic review and meta-analysis', Lancet Public Health, 9, pp. e594 - e613, http://dx.doi.org/10.1016/S2468-2667(24)00126-9

Darke S; Farrell M; Duflou J; Lappin J, 2024, 'Chronic obstructive pulmonary disease in heroin users: An underappreciated issue with clinical ramifications', Addiction, 119, pp. 1153 - 1155, http://dx.doi.org/10.1111/add.16407

Bharat C; Farrell M, 2024, 'National approaches to reduce mortality after prison release', Lancet Public Health, 9, pp. e412 - e413, http://dx.doi.org/10.1016/S2468-2667(24)00105-1

Lawson S; Bryant J; Freund M; Dizon J; Haber PS; Shakeshaft A; Jefferies M; Farrell M, 2024, 'Prevalence and factors associated with polydrug use among clients seeking treatment for alcohol misuse', Drug and Alcohol Review, 43, pp. 1194 - 1203, http://dx.doi.org/10.1111/dar.13833

Clay S; Wilkinson Z; Ginley M; Arunogiri S; Christmass M; Membrey D; MacCartney P; Sutherland R; Colledge-Frisby S; Marshall AD; Nagle J; Degenhardt L; Farrell M; McKetin R, 2024, 'The reflections of health service providers on implementing contingency management for methamphetamine use disorder in Australia', Drug and Alcohol Review, 43, pp. 1313 - 1322, http://dx.doi.org/10.1111/dar.13853

Webb P; Ireland J; Colledge-Frisby S; Peacock A; Leung J; Vickerman P; Farrell M; Hickman M; Grebely J; Degenhardt L, 2024, 'Patterns of drug use among people who inject drugs: A global systematic review and meta-analysis', International Journal of Drug Policy, 128, http://dx.doi.org/10.1016/j.drugpo.2024.104455

Farrell M; Shahbazi J; Chambers M; Byrne M; Gholami J; Zahra E; Grebely J; Lintzeris N; Larance B; Ali R; Nielsen S; Dunlop A; Dore GJ; McDonough M; Montebello M; Weiss R; Rodgers C; Cook J; Degenhardt L, 2024, '96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial', International Journal of Drug Policy, 127, http://dx.doi.org/10.1016/j.drugpo.2024.104390

Darke S; Duflou J; Peacock A; Chrzanowska A; Yuen WS; Farrell M; Lappin J, 2024, 'Characteristics, toxicology and major organ pathology of deaths due to acute alcohol toxicity in Australia, 2011–2022', Drug and Alcohol Review, 43, pp. 937 - 945, http://dx.doi.org/10.1111/dar.13817

Tran AD; Grebely J; Chambers M; Degenhardt L; Farrell M; Bajis S; Larance B, 2024, 'Health utility among people who regularly use opioids in Australia', Drug and Alcohol Review, 43, pp. 997 - 1012, http://dx.doi.org/10.1111/dar.13823

Black N; Chung S; Tisdale C; Fialho LS; Aramrattana A; Assanangkornchai S; Blaszczynski A; Bowden-Jones H; van den Brink W; Brown A; Brown QL; Cottler LB; Elsasser M; Ferri M; Florence M; Gueorguieva R; Hampton R; Hudson S; Kelly PJ; Lintzeris N; Murphy L; Nadkarni A; Neale J; Rosen D; Rumpf HJ; Rush B; Segal G; Shorter GW; Torrens M; Wait C; Young K; Farrell M, 2024, 'An International, Multidisciplinary Consensus Set of Patient-Centered Outcome Measures for Substance-Related and Addictive Disorders', Journal of Clinical Medicine, 13, http://dx.doi.org/10.3390/jcm13072154

Hall W; Darke S; Farrell M, 2024, 'Do we need clinical trials of high dose stimulant agonist treatment for stimulant use disorders?', Addiction, 119, pp. 786 - 787, http://dx.doi.org/10.1111/add.16416

Acheson LS; Clay S; McKetin R; Lintzeris N; Dunlop A; Brett J; Christmass M; Rodgers C; Shoptaw S; Farrell M; Ezard N; Siefried KJ, 2024, 'Participant experiences in a pilot study for methamphetamine withdrawal treatment: Implications for retention', International Journal of Drug Policy, 126, pp. 104383, http://dx.doi.org/10.1016/j.drugpo.2024.104383

Lancaster K; Gendera S; Treloar C; Rhodes T; Shahbazi J; Byrne M; Nielsen S; Degenhardt L; Farrell M, 2024, 'Tinkering with care: Implementing extended-release buprenorphine depot treatment for opioid dependence', International Journal of Drug Policy, 126, pp. 104359, http://dx.doi.org/10.1016/j.drugpo.2024.104359

Back to profile page